AsiaMedic Limited (SGX:505)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0180
0.00 (0.00%)
At close: Mar 20, 2026

AsiaMedic Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2.021.011.922.190.72
Depreciation & Amortization
3.382.472.071.051.27
Loss (Gain) From Sale of Assets
-1.97----
Asset Writedown & Restructuring Costs
-0-0.07-0.12-0.950.86
Loss (Gain) From Sale of Investments
0.010.01---
Loss (Gain) on Equity Investments
0.63-0.32-0.44-0.48-0.36
Stock-Based Compensation
0.020.020.01--
Provision & Write-off of Bad Debts
---0.02-
Other Operating Activities
0.090.06-0.610.20.32
Change in Accounts Receivable
-3.01-1.520.09-0.860.29
Change in Inventory
0.060.05-0.1-0.010.02
Change in Accounts Payable
2.070.990.730.260.5
Change in Unearned Revenue
0.57-0.22-0.13-0.19-0.18
Operating Cash Flow
3.882.483.411.233.44
Operating Cash Flow Growth
56.35%-27.32%176.73%-64.11%47.38%
Capital Expenditures
-2.68-1.81-2.43-1-0.38
Sale of Property, Plant & Equipment
0.07----
Cash Acquisitions
-0.21----
Investment in Securities
-0.551.49-2.99-1.98-
Other Investing Activities
0.380.530.560.330.32
Investing Cash Flow
-2.980.21-4.86-2.65-0.06
Long-Term Debt Issued
--0.61--
Long-Term Debt Repaid
-2.31-1.81-1.13-1.08-1.42
Net Debt Issued (Repaid)
-2.31-1.81-0.52-1.08-1.42
Other Financing Activities
-0.882.5-0.07-0.33-0.14
Financing Cash Flow
-3.190.69-0.59-1.41-1.56
Net Cash Flow
-2.33.39-2.04-2.831.82
Free Cash Flow
1.20.680.980.233.06
Free Cash Flow Growth
78.08%-31.31%319.99%-92.34%54.27%
Free Cash Flow Margin
3.38%2.32%4.14%1.23%16.60%
Free Cash Flow Per Share
0.000.000.00-0.00
Cash Interest Paid
0.880.590.420.240.14
Levered Free Cash Flow
1.752.53-4.05-0.381.25
Unlevered Free Cash Flow
2.322.9-3.79-0.231.34
Change in Working Capital
-0.31-0.70.59-0.780.63
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.